Literature DB >> 20146713

Phosphoinositide 3-kinase and the mammalian target of rapamycin pathways control T cell migration.

David Finlay1, Doreen Cantrell.   

Abstract

The established role for phosphatidylinositol (3,4,5) triphosphate (PI(3,4,5)P3) signaling pathways is to regulate cell metabolism. More recently it has emerged that PI(3,4,5)P3 signaling via mammalian target of rapamycin and Foxo transcription factors also controls lymphocyte trafficking by determining the repertoire of adhesion and chemokine receptors expressed by T lymphocytes. In quiescent T cells, nonphosphorylated active Foxos maintain expression of KLF2, a transcription factor that regulates expression of the chemokine receptors CCR7 and sphingosine 1 phosphate receptor, and the adhesion receptor CD62L that together control T-cell transmigration into secondary lymphoid tissues. PI(3,4,5)P3 mediates activation of protein kinase B, which phosphorylates and inactivates Foxos, thereby terminating expression of KLF2 and its target genes. The correct localization of lymphocytes is essential for effective immune responses, and the ability of phosphoinositide 3-kinase and mammalian target of rapamycin to regulate expression of chemokine receptors and adhesion molecules puts these signaling molecules at the core of the molecular mechanisms that control lymphocyte trafficking.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146713      PMCID: PMC3520021          DOI: 10.1111/j.1749-6632.2009.05134.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  63 in total

1.  Cutting edge: T cell requirement for CD28 costimulation is due to negative regulation of TCR signals by PTEN.

Authors:  Jodi L Buckler; Patrick T Walsh; Paige M Porrett; Yongwon Choi; Laurence A Turka
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

2.  Kruppel-like factor 2 regulates thymocyte and T-cell migration.

Authors:  Corey M Carlson; Bart T Endrizzi; Jinghai Wu; Xiaojie Ding; Michael A Weinreich; Elizabeth R Walsh; Maqsood A Wani; Jerry B Lingrel; Kristin A Hogquist; Stephen C Jameson
Journal:  Nature       Date:  2006-07-20       Impact factor: 49.962

3.  CD62L (L-selectin) down-regulation does not affect memory T cell distribution but failure to shed compromises anti-viral immunity.

Authors:  Hannah Richards; M Paula Longhi; Kate Wright; Awen Gallimore; Ann Ager
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

4.  Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition.

Authors:  Changchuin Mao; Esmerina G Tili; Marei Dose; Mariëlle C Haks; Susan E Bear; Ioanna Maroulakou; Kyoji Horie; George A Gaitanaris; Vincenzo Fidanza; Thomas Ludwig; David L Wiest; Fotini Gounari; Philip N Tsichlis
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

5.  T lymphocyte rolling and recruitment into peripheral lymph nodes is regulated by a saturable density of L-selectin (CD62L).

Authors:  Elena Galkina; Oliver Florey; Alexander Zarbock; Bryan R E Smith; Graham Preece; Michael B Lawrence; Dorian O Haskard; Ann Ager
Journal:  Eur J Immunol       Date:  2007-05       Impact factor: 5.532

6.  Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation.

Authors:  Marisa M Juntilla; Jessica A Wofford; Morris J Birnbaum; Jeffrey C Rathmell; Gary A Koretzky
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-03       Impact factor: 11.205

7.  Kruppel-like factor 2 controls T cell trafficking by activating L-selectin (CD62L) and sphingosine-1-phosphate receptor 1 transcription.

Authors:  Ailin Bai; Hui Hu; Mandy Yeung; Jianzhu Chen
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

Review 8.  AKT/PKB signaling: navigating downstream.

Authors:  Brendan D Manning; Lewis C Cantley
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

10.  Notch-induced T cell development requires phosphoinositide-dependent kinase 1.

Authors:  April P Kelly; David K Finlay; Heather J Hinton; Rosie G Clarke; Emma Fiorini; Freddy Radtke; Doreen A Cantrell
Journal:  EMBO J       Date:  2007-06-28       Impact factor: 11.598

View more
  43 in total

1.  Harnessing autophagy for adoptive T-cell therapy.

Authors:  Shoba Amarnath; Daniel H Fowler
Journal:  Immunotherapy       Date:  2012-01       Impact factor: 4.196

2.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

Review 3.  Decision checkpoints in the thymus.

Authors:  Andrea C Carpenter; Rémy Bosselut
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 4.  The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism.

Authors:  Jonathan D Powell; Greg M Delgoffe
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

5.  Fox factors fight over T cell quiescence.

Authors:  Cara N Skon; Stephen C Jameson
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

6.  Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.

Authors:  Mai Fujiwara; Emily J Anstadt; Kamal M Khanna; Robert B Clark
Journal:  Clin Immunol       Date:  2015-03-28       Impact factor: 3.969

Review 7.  Role of diacylglycerol kinases in T cell development and function.

Authors:  Sruti Krishna; Xiaoping Zhong
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

8.  OutFOXing myeloid cells in atherosclerosis with FoxOs.

Authors:  Mark W Feinberg
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

Review 9.  Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection.

Authors:  Ying-Chun Lo; Chen-Fang Lee; Jonathan D Powell
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

10.  Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naive human CD4+ T lymphocytes.

Authors:  John G Foster; Edward Carter; Iain Kilty; Amanda B MacKenzie; Stephen G Ward
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.